These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6141285)

  • 1. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA; Stiles GL; Shand DG
    J Pharmacol Exp Ther; 1984 Feb; 228(2):461-6. PubMed ID: 6141285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
    Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE; Wahl RA; Branscheid D; Roeher HD
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor blocking activity of diprafenone in anesthetized dogs: comparison with propafenone and propranolol.
    Greenberg S; Cantor E; Paul J
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):444-53. PubMed ID: 2476625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
    Galant SP; Allred SJ
    J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.
    Lee JT; Kroemer HK; Silberstein DJ; Funck-Brentano C; Lineberry MD; Wood AJ; Roden DM; Woosley RL
    N Engl J Med; 1990 Jun; 322(25):1764-8. PubMed ID: 1971708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
    von Philipsborn G; Gries J; Hofmann HP; Kreiskott H; Kretzschmar R; Müller CD; Raschack M; Teschendorf HJ
    Arzneimittelforschung; 1984; 34(11):1489-97. PubMed ID: 6543124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.
    Chatelain P; Meysmans L; Mattéazzi JR; Beaufort P; Clinet M
    Br J Pharmacol; 1995 Oct; 116(3):1949-56. PubMed ID: 8640331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
    Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
    Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
    Stoschitzky K; Klein W; Stark G; Stark U; Zernig G; Graziadei I; Lindner W
    Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological studies on alterations in myocardial beta-adrenoceptors and their intracellular signal transduction in experimental diabetic rats].
    Gando S
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1140-53. PubMed ID: 7868054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
    Barovsky K; Pedone C; Brooker G
    Mol Pharmacol; 1984 Mar; 25(2):256-60. PubMed ID: 6321948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
    Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
    Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrophysiologic and anti-arrhythmia properties of propafenone deducible from experimental studies in vitro].
    Ledda F; Mantelli L
    G Ital Cardiol; 1984 Apr; 14(4):279-84. PubMed ID: 6329868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
    Persad S; Takeda S; Panagia V; Dhalla NS
    J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S; Hattori Y; Akaishi Y; Nishihira J; Kanno M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):475-84. PubMed ID: 9223590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology and beta-blocking efficacy of propafenone.
    Barbey JT
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S41-3. PubMed ID: 1723117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the beta-adrenoceptor blocking activity of the Class Ic antiarrhythmic drug diprafenone in man.
    Wagner F; Jähnchen E; Trenk D
    Eur J Clin Pharmacol; 1989; 36(6):579-82. PubMed ID: 2570700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization.
    Nanoff C; Schütz W
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):837-42. PubMed ID: 1725895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.